ATEA PHARMACEUTICALS, INC. — Key Metrics
1 years of history · ending 2021-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$1
Book Value Per Share
$8
Free Cash Flow Per Share
$-1
Cash Per Share
$9
Revenue Per Share
$4
OCF Per Share
$-1
Return on Equity
19.3%
Return on Assets
14.8%
Return on Invested Capital
19.2%
Current Ratio
13.58
Quick Ratio
13.58
Asset Turnover
0.43
R&D / Revenue
47.6%
SBC / Revenue
11.3%
Capex / Revenue
0.0%
Working Capital
$716M
Net Current Asset Value
$710M
Invested Capital
$710M
OCF / Net Income
-0.72
FCF / Net Income
-0.72
Accruals Ratio (Sloan)
26.9%
Net Debt
$-764M
Net Debt / EBITDA
-5.52
Capex Coverage
-21751.25
Tangible Common Equity
$710M
TCE / Total Assets
91.9%
NOPAT
$121M
Cash ROIC
-13.8%
WC / Revenue
203.6%
Capex / D&A
0.14
Reinvestment Rate
-0.0%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-633.0%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$9
Market Cap
$789M
P/E Ratio
6.51
P/S Ratio
2.25
P/B Ratio
1.11
P/TB Ratio
1.11
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$25M
EV / EBITDA
0.18
EV / Sales
0.07
EV / FCF
—
FCF Yield
-11.0%
Shareholder Yield
-5.0%
Buyback Yield
—
R&D Yield
21.2%
Capex Yield
0.0%
Graham Number
$16
Shares Variation (YoY)
308.7%
Beta (5Y)
0.17
Cost of Equity
5.3%
52W High
$88
52W Low
$8
Trailing Return 1Y
-78.6%
Trailing Return 5Y
—
F-Score (Piotroski)
4.00
Z-Score (Altman)
9.79
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.